University Hospital, Montpellier: Carcinoma, Hepatocellular trials

The registry lists 11 Carcinoma, Hepatocellular studies with University Hospital, Montpellier as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 2 3No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Liver Cancer and Immunotherapy in the Liquid Biopsy EraRecruitingNCT05810402Not applicable
• Screening for Chronic Liver Diseases in General PopulationActive, not recruitingNCT06366425Not applicable
• Pathological Results of Aggressive Hepatocellular Carcinomas Treated Using SIRTCompletedNCT05045573
• Neoadjuvant Atezo, Adjuvant Atezo + Beva Combined With RF Ablation of Small HCC: a Multicenter Randomized Phase II TrialActive, not recruitingNCT04727307Phase 2
• Discrepancies in Management of Hepatocellualr Carcinoma Between Practice and RecommendationsStatus unknownNCT04189809
• The Impact on Hepatic Recurrence After Adjuvant Chemotherapy With Intraarterial Infusion of Idarubicin-LipiodolWithdrawnNCT04178642Phase 2
• Changing Trends in HCC ProceduresStatus unknownNCT04163627
• Hepatocellular Carcinoma on Cirrhosis With Child A/B7 and Hepatic Intra Arterial Injection of Idarubicin/Lipiodol EmulsionTerminatedNCT03727633Phase 2
• Small and Steatotic Hepatocellular CarcinomaCompletedNCT03428321
• TACE for HCC by TANDEM and IdarubicinCompletedNCT03349957
• Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative TreatmentStatus unknownNCT01492127Not applicable